The efficancy of pregabalin for peripheral neuropathic pain in spinal disease

The efficancy of pregabalin for peripheral neuropathic pain in spinal disease - peripheral neuropathic pain in spinal disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005938

Enrollment

100

Registered

2011-07-07

Start date

2011-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal disease

Interventions

pregabalin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Age 20-80yo 2.the patients with peripheral neuropathic pain in spinal disease 3.Normal renal function 4.concent with the trail

Exclusion criteria

Exclusion criteria: 1.renal dysfunction,heart failure,liver dysfunction 2.A pregnant woman,woman in child bed,nursing mother 3.Determination as contratindication by doctors

Design outcomes

Primary

Measure	Time frame
Visual analog scale	—

Secondary

Measure	Time frame
Self-Rating Depression Scale	—

Countries

Japan

Contacts

Public ContactTomoko Tetsunaga

Okayama University Hospital Dept.of Orthop.Surg.

0862357273

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026